Key Insights

Highlights

Success Rate

96% trial completion (above average)

Published Results

29 trials with published results (26%)

Research Maturity

89 completed trials (79% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

3.5%

4 terminated out of 113 trials

Success Rate

95.7%

+9.2% vs benchmark

Late-Stage Pipeline

40%

45 trials in Phase 3/4

Results Transparency

33%

29 of 89 completed with results

Key Signals

29 with results96% success

Data Visualizations

Phase Distribution

101Total
Not Applicable (30)
P 1 (8)
P 2 (18)
P 3 (29)
P 4 (16)

Trial Status

Completed89
Withdrawn7
Terminated4
Recruiting4
Unknown4
Not Yet Recruiting4

Trial Success Rate

95.7%

Benchmark: 86.5%

Based on 89 completed trials

Clinical Trials (113)

Showing 20 of 20 trials
NCT07642648Phase 2Not Yet Recruiting

A Novel Cold and Flu Herbal Blend for Reducing the Duration and Severity of the Common Cold

NCT07625683Not Yet Recruiting

Observational Study of SIROPSEDAL in Acute Cough

NCT07620522Not Yet Recruiting

Observational Study of RHINOSEDAL in Acute Nasal Obstruction

NCT06724185Not ApplicableCompletedPrimary

Effects of LP28 on Immunity Enhancement in the Elderly

NCT00448981Not ApplicableCompleted

Stopping Upper Respiratory Infections and Flu in the Family: The Stuffy Trial

NCT06716645Phase 4CompletedPrimary

A Clinical Evidence Study Evaluating Quality of Life Parameters Following Treatment With Robitussin

NCT07257224Not Yet Recruiting

Post-market Clinical Follow-up Study of an Isotonic Saline Solution to Manage Nasal Congestion in Case of Flu Symptoms, Colds, Allergic Rhinitis and Rhinosinusitis in Infants and Toddlers

NCT07246850Not ApplicableActive Not Recruiting

A Randomized, Triple-blind, Placebo-controlled Study to Evaluate the Effects of a Throat Spray on the Incidence and Duration of Sickness

NCT06278324Not ApplicableCompleted

Effectiveness of a Nasal Spray on Viral Respiratory Infections

NCT06005337Not ApplicableCompletedPrimary

Supporting Parents to Choose Wisely

NCT06497439Phase 2CompletedPrimary

Efficacy and Safety of Silfamin for Common Cold

NCT05034328CompletedPrimary

Symbiofilm Trial in Allergic Kids (SYMBIOFILM-TAK)

NCT06697886Phase 3RecruitingPrimary

A Study of the Efficacy and Safety of Antiwei Granules in the Treatment of Common Cold

NCT05819203Not ApplicableCompletedPrimary

BАbykids Spray In Common Cold

NCT05819190Not ApplicableCompletedPrimary

Testing the Efficacy in Adults With Cold of HEalsea Rescue*

NCT05244148Not ApplicableTerminatedPrimary

Two Seawater-based Formulations for Relief of Nasal Congestion in Paediatric Subjects

NCT05070650Phase 3WithdrawnPrimary

Efficacy and Safety of the Combination of Acetylcysteine, Paracetamol and Phenylephrine for the Treatment of Common Cold

NCT02522949Not ApplicableCompletedPrimary

Evaluation of ColdZyme® Mouth Spray on Prevention and Alleviation of Rhinovirus Induced Common Cold

NCT06531707Phase 3RecruitingPrimary

Efficacy and Safety in the Combination of Ibuprofen / Loratadine Versus Ibuprofen Versus Loratadine

NCT04368520Phase 2WithdrawnPrimary

Clinical Trial to Optimise Levels of Vitamin D for Rhinovirus Protection

Scroll to load more

Research Network

Activity Timeline